News
2h
Zacks Investment Research on MSNIs it Worth Retaining Boston Scientific Stock in Your Portfolio Now?Boston Scientific’s BSX first-quarter 2025 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...
Boston Scientific strutted into the Bank of America Healthcare Conference with a swagger backed by 18.2% organic revenue ...
A spokesperson for Hyundai said the robots will not impact the 8,500 jobs the automaker has pledged to bring to the region.
BOSTON (AP) — BOSTON (AP) — Elicio Therapeutics, Inc. (ELTX) on Tuesday reported a loss of $11.2 million in its first quarter. The Boston-based company said it had a loss of 87 cents per share.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results